Starmer's bold plan to cut UK drug prices
Labour leader Keir Starmer vows to confront pharmaceutical giants over soaring drug prices, promising relief for the NHS and patients. Will his strategy work?
Labour leader Keir Starmer vows to confront pharmaceutical giants over soaring drug prices, promising relief for the NHS and patients. Will his strategy work?
Former US President Donald Trump calls on British pharmaceutical companies to reduce drug prices for the NHS, sparking debate on healthcare affordability.
New US tariffs could drastically increase the cost of essential medicines in Australia, putting the Pharmaceutical Benefits Scheme at risk. Experts warn of dire consequences for patients.
Biotech leader Moderna announces major layoffs, axing 150 jobs as part of a strategic cost-reduction plan. What does this mean for the future of mRNA vaccines?
AstraZeneca's CEO highlights the critical role of the US market amid looming Trump tariffs, emphasising the need for stable trade policies to sustain pharmaceutical innovation.
Novo Nordisk's blockbuster weight-loss drug Wegovy drives record sales, boosting shares and intensifying competition with Eli Lilly.
Pharmaceutical giant AstraZeneca faces a sharp decline in share prices following an unfavourable US court ruling, sparking investor concerns.
A US couple has been sentenced after authorities discovered their home packed with illegal erectile dysfunction drugs worth thousands.
Pharmaceutical giant AstraZeneca announces a bold $1.5bn US expansion despite looming tariff threats from the Trump administration, signalling confidence in transatlantic trade resilience.